Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA approves Skyrizi for moderate to severe plaque psoriasis

April 24, 2019

Positive initial phase II data for nomacopan in bullous pemphigoid

April 24, 2019

Identification of selective, orally active RORgammat inverse agonists

April 24, 2019

Skin microbiome study gives insights into wound healing

April 23, 2019

Otsuka Pharmaceutical initiates two phase III studies of OPA-15406 ointment

April 17, 2019

Phase I/IIa trial of antibody-inducing peptide FPP-003 begins in Australia

April 17, 2019

Positive 12-month data presented from phase II study of Clascoterone

April 16, 2019

Mallinckrodt, Washington University to jointly search for drugs targeting chronic itch

April 12, 2019

Mechanism underlying youthful and aging skin found in mice

April 10, 2019

New phase I trial explores use of UB-221 for chronic spontaneous urticaria

April 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.